Suchergebnisse - "Li, Xiaoning"

PubPharm (467)

51

Folic acid-maltodextrin polymer coated magnetic graphene oxide as a NIR-responsive nano-drug delivery system for chemo-photothermal synergistic inhibition of tumor cells

enthalten in: RSC advances | 2023

von Gong, T. | Wang, X. | Zhu, H. | +6

52

Highly Oxidized Oxide Surface toward Optimum Oxygen Evolution Reaction by Termination Engineering

enthalten in: ACS nano | 2023

von Li, X. | Ge, L. | Du, Y. | +7

53

Risk Factors Associated with Adverse Outcomes after Ablative Surgery for Lymphedema

enthalten in: Journal of reconstructive microsurgery | 2023

von Kuruvilla, A. | Shroyer, A. | Li, X. | +7

54

Preparation method and application of pig IKK alpha polyclonal antibody

enthalten in: Europäisches Patentamt | 2023

von LUO TINGRONG | LI XIAONING | JIN YIXIN | +2

55

Preparation method and application of pig IKK alpha polyclonal antibody

enthalten in: Europäisches Patentamt | 2023

von LUO TINGRONG | LI XIAONING | JIN YIXIN | +2

56

Preparation of AlON Powder by Carbothermal Reduction and Nitridation with Assisting by Silane Coupling Agent

enthalten in: Materials (Basel, Switzerland) | 2023

von Xue, Z. | Wang, X. | Liu, Y. | +4

57

Combining ab initio and ab initio molecular dynamics simulations to predict the complex refractive indices of organic polymers

enthalten in: Physical chemistry chemical physics : PCCP | 2023

von Wang, C. | Li, X. | Liu, L.

58

Host Desmin Interacts with RABV Matrix Protein and Facilitates Virus Propagation

enthalten in: Viruses | 2023

von Zhang, W. | Liu, Y. | Li, M. | +4

59

Targeting B4GALT7 suppresses the proliferation, migration and invasion of hepatocellular carcinoma through the Cdc2/CyclinB1 and miR-338-3p/MMP2 pathway

enthalten in: PeerJ | 2023

von Liu, C. | Jia, Y. | Zhao, X. | +16

60

The Effect of Molecular Conformations and Simulated "Self-Doping" in Phenothiazine Derivatives on Room-Temperature Phosphorescence

enthalten in: Angewandte Chemie (International ed. in English) | 2023

von Gao, M. | Tian, Y. | Li, X. | +4